Alice Sanchez
Psychiatry · Frisco, TXNPI 1053516534
Payments from drug & device makers
Across 208 payments — averaging $20.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Neurocrine Biosciences, Inc.$631
- Johnson & Johnson$532
- Corium, LLC$390
- Alkermes, Inc.$275
- Brainsway USA Inc$166
- plus $1K from 17 others
What the payments were for
- Food & beverage$4,277100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 63 | $1,097 |
| Neurocrine Biosciences, Inc. | 27 | $631 |
| Johnson & Johnson | 16 | $532 |
| Corium, LLC | 26 | $390 |
| Alkermes, Inc. | 12 | $275 |
| Brainsway USA Inc | 2 | $166 |
| Otsuka America Pharmaceutical, Inc. | 9 | $158 |
| Axsome Therapeutics, Inc. | 6 | $136 |
| Sunovion Pharmaceuticals Inc. | 8 | $132 |
| Lundbeck LLC | 5 | $108 |
| Tris Pharma Inc | 5 | $107 |
| Idorsia Pharmaceuticals US Inc | 5 | $94 |
| Noven Therapeutics, LLC | 5 | $84 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $82 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $65 |
| Teva Pharmaceuticals USA, Inc. | 3 | $58 |
| Supernus Pharmaceuticals, Inc. | 2 | $37 |
| Medline Industries LP | 1 | $33 |
| Vanda Pharmaceuticals Inc. | 1 | $23 |
| OWP Pharmaceuticals, Inc. | 1 | $21 |
| Neuronetics, Inc. | 1 | $17 |
| Bioxcel Therapeutics, Inc. | 1 | $17 |
| Vertical Pharmaceuticals, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPRAVATO$130
- Deep TMS System$102
How this compares
$4,277 in reported general payments places this provider in the 80th percentile of 2,238 psychiatry providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 32 | $995 |
| Zolpidem Tartrate | 12 | $281 |
| Lamotrigine | 12 | $215 |
| Aripiprazole | 11 | $195 |
| Alprazolam | 12 | $118 |
| Gabapentin | 14 | $111 |
| Buspirone Hcl | 12 | $107 |
| Trazodone Hcl | 20 | $105 |
| Escitalopram Oxalate | 13 | $76 |
| Quetiapine Fumarate | 21 | $20 |
| Sertraline Hcl | 12 | $11 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Frisco
- Writtika RoyFrisco$1.3M
- Scott BartleyDallas$42.7M
- David BrownAustin$15.8M
- Rajinder ShiwachDesoto$15.4M
- Darin OkudaDallas$14.7M
- Jason MensahBeaumont$10.3M
- Michael DowningDallas$7.6M
- Rakesh JainLake Jackson$7.2M
- Suresh SureddiPlano$5.9M
- Marshall LucasThe Woodlands$4.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.